List of insiders holdings for PALVELLA THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC ISALY SAMUEL D 10% Owner |
2018-09-27 16:43:06 | 2,455,900 0 |
2,455,900 | Form 13D |
2 | ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC See Remarks 10% Owner |
2018-09-27 16:43:06 | 2,455,900 0 |
2,455,900 | Form 13D |
3 | Aquilo Capital Management LLC 10% Owner |
2024-02-14 16:37:34 | 1,126,761 0 |
1,126,761 | Form 13G |
4 | Yoder Stephen S. Chief Executive Officer |
2023-02-28 17:09:07 | 634,021 0 |
634,021 | Form 4 |
5 | Knopf Claude Chief Business Officer |
2016-11-30 20:24:21 | 500,000 0 |
500,000 | Form 4 |
6 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2024-12-17 17:44:27 | 493,205 0 |
493,205 | Form 4 |
7 | Bures Thomas Chief Financial Officer |
2023-02-28 17:39:15 | 249,080 0 |
249,080 | Form 4 |
8 | Kaufmann Hitto Chief Scientific Officer |
2023-02-28 17:35:58 | 249,080 0 |
249,080 | Form 4 |
9 | Mousa Ahmed Chief Business Officer |
2023-02-28 17:31:30 | 249,080 0 |
249,080 | Form 4 |
10 | Olwill Shane Chief Development Officer |
2023-02-28 17:23:53 | 249,080 0 |
249,080 | Form 4 |
11 | Kaupinen Wes President and CEO |
2025-02-10 18:25:31 | 243,831 0 |
243,831 | Form 4/A |
12 | JENKINS GEORGE M Director |
2025-04-10 19:06:12 | 183,171 13,516 |
196,687 | Form 4 |
13 | Reine Allan Chief Financial Officer |
2019-02-28 17:24:24 | 162,500 0 |
162,500 | Form 4 |
14 | Dellora Investments LP no longer 10% owner |
2024-12-17 16:22:06 | 141,079 0 |
141,079 | Form 13G |
15 | PALVELLA THERAPEUTICS INC. Chief Scientific Officer |
2025-02-07 16:30:31 | 128,932 0 |
128,932 | Form 4 |
16 | Korenberg Matthew E CFO and Treasurer |
2025-02-10 17:21:33 | 128,932 0 |
128,932 | Form 4/A |
17 | Goin Kathleen Chief Operating Officer |
2025-02-10 17:40:29 | 128,932 0 |
128,932 | Form 4/A |
18 | Martini Jeffrey S Chief Scientific Officer |
2025-02-10 18:00:29 | 128,932 0 |
128,932 | Form 4/A |
19 | Matis Louis Chief Development Officer |
2019-02-28 17:25:09 | 96,500 0 |
96,500 | Form 4 |
20 | Sherman Matthew L Director |
2023-06-23 16:45:31 | 40,000 0 |
40,000 | Form 4 |
21 | Barbier Ann Director |
2023-06-23 16:47:16 | 40,000 0 |
40,000 | Form 4 |
22 | Kiener Peter A Director |
2023-06-23 16:46:34 | 40,000 0 |
40,000 | Form 4 |
23 | Richman Michael Director |
2023-06-23 16:45:50 | 40,000 0 |
40,000 | Form 4 |
24 | Said Maya R. Director |
2023-06-23 16:45:37 | 40,000 0 |
40,000 | Form 4 |
25 | Takke Christina Director |
2015-06-29 21:22:52 | 30,000 0 |
30,000 | Form 3 |
26 | KIRITSY CHRISTOPHER P Director |
2024-12-17 20:40:43 | 24,700 0 |
24,700 | Form 4 |
27 | Davis Todd C Director |
2024-12-17 20:44:40 | 24,700 0 |
24,700 | Form 4 |
28 | Wessel Tadd S. Director |
2024-12-17 20:45:10 | 24,700 0 |
24,700 | Form 4 |
29 | HERON ELAINE J Director |
2024-12-17 20:46:08 | 24,700 0 |
24,700 | Form 4 |
30 | BIZZARI JEAN-PIERRE Director |
2020-01-28 16:19:48 | 20,000 0 |
20,000 | Form 4 |
31 | Prelack Steven Director |
2019-01-29 17:42:26 | 20,000 0 |
20,000 | Form 4 |
32 | ADAMS JULIAN Director |
2018-01-29 16:40:30 | 20,000 0 |
20,000 | Form 4 |
33 | ADAR1 Capital Management LLC ADAR1 Partners LP 10% Owner |
2024-08-12 18:48:13 | 0 15,067 |
15,067 | Form 4 |
34 | Khuong Chau Quang Director 10% Owner |
2017-10-27 16:26:13 | 6,115 0 |
6,115 | Form 4 |
35 | Demuth Tim Chief Medical Officer |
2022-05-16 20:19:05 | 6,000 0 |
6,000 | Form 4 |
36 | DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer |
2016-06-15 17:00:41 | 5,000 0 |
5,000 | Form 4 |
37 | GERAGHTY JAMES A Director |
2024-12-12 16:16:43 | 0 0 |
0 | Form 4 |
38 | THIBAULT LANCE E Acting Chief Financial Officer |
2017-02-13 18:00:41 | 0 0 |
0 | Form 3 |